Ovarian cancer Trials in Montvale, United States
Conditions / Ovarian cancer / Montvale, United States
Clinical trials for Ovarian cancer investigate a range of treatment strategies and patient populations.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06290193 | Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery | RECRUITING | PHASE2 |
| NCT05059522 | Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing | ACTIVE_NOT_RECRUITING | — |
| NCT05429970 | A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) | RECRUITING | NA |
| NCT07303894 | A Study of Isoquercetin in People With Ovarian Cancer | RECRUITING | — |
| NCT05053230 | A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer | RECRUITING | NA |
| NCT04878094 | A Study of Intra-operative Imaging in Women With Ovarian Cancer | RECRUITING | PHASE3 |
| NCT01767675 | Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | COMPLETED | PHASE2 |
| NCT03761914 | Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers | COMPLETED | PHASE1/PHASE2 |
| NCT00579488 | Clinical Significance of Germline BRCA Mutations | ACTIVE_NOT_RECRUITING | — |
| NCT02737787 | A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer | COMPLETED | PHASE1 |